First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - CRESCENDO BIOLOGICS LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: CRESCENDO BIOLOGICS LIMITED, MEDITRINA BUILDING, BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CB22 3AT. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 13 November 2007.

The accounts next due date is 30 September 2024. There is 1 mortgage, which is unsatisfied

The above was based on public record information as at 22 October 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 06425006
Date Incorporated: 13 November 2007
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: TRANSLOCUS LIMITED
Registered Number: 06425006
Annual Return: 30 June 2015
Registered Office: MEDITRINA BUILDING, BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CB22 3AT
SIC Code and Operations: 72110
SECURED CREDITORS
Number of Mortgages 1
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 1
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

CRESCENDO BIOLOGICS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 1 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
OC385592 CRESCENDO BOARD PRACTICE LLP Active
11189018 CRESCENDO BRAND EVENTS LIMITED Active
10230624 CRESCENDO BUSINESS SOLUTIONS LTD Dissolved
13542576 CRESCENDO CAPITAL GROUP LTD Active - Proposal to Strike off
13472947 CRESCENDO CAPITAL LIMITED Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd